Lichen planus, lichenoid drug reactions, and lichenoid mucositis

Scott S. DeRossi, Katharine N. Ciarrocca

Research output: Contribution to journalReview article

52 Citations (Scopus)

Abstract

OLP and lichenoid reaction are a relatively common oral mucosal disease process encountered in clinical practice. This mucocutaneous disease can manifest as desquamative gingivitis, asymptomatic Wickham's striae or plaques, or severe, painful erosions or ulcerations anywhere in the oral cavity. Although the exact agent initiating LP is unknown, current research points to a number of complex immunologic events and cells that are responsible for the inflammatory destruction and chronicity of these lesions. Currently, the mainstay of treatment remains topical corticosteroids, but newer therapies such a tacrolimus are available for recalcitrant lesions. In cases of lichenoid mucositis or reactions, treatment should always be directed toward identifying and removing the presumed causative agent. Given the apparent risk of squamous cell carcinoma in these patients, frequent follow-up and repeat biopsy when indicated are vital.

Original languageEnglish (US)
Pages (from-to)77-89
Number of pages13
JournalDental Clinics of North America
Volume49
Issue number1 SPEC.ISS.
DOIs
StatePublished - Jan 1 2005

Fingerprint

Lichen Planus
Mucositis
Mouth Diseases
Pharmaceutical Preparations
Gingivitis
Tacrolimus
Mouth
Squamous Cell Carcinoma
Adrenal Cortex Hormones
Therapeutics
Biopsy
Research

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Lichen planus, lichenoid drug reactions, and lichenoid mucositis. / DeRossi, Scott S.; Ciarrocca, Katharine N.

In: Dental Clinics of North America, Vol. 49, No. 1 SPEC.ISS., 01.01.2005, p. 77-89.

Research output: Contribution to journalReview article

DeRossi, Scott S. ; Ciarrocca, Katharine N. / Lichen planus, lichenoid drug reactions, and lichenoid mucositis. In: Dental Clinics of North America. 2005 ; Vol. 49, No. 1 SPEC.ISS. pp. 77-89.
@article{249db1bc4fb547f1ad6c17678b521fd7,
title = "Lichen planus, lichenoid drug reactions, and lichenoid mucositis",
abstract = "OLP and lichenoid reaction are a relatively common oral mucosal disease process encountered in clinical practice. This mucocutaneous disease can manifest as desquamative gingivitis, asymptomatic Wickham's striae or plaques, or severe, painful erosions or ulcerations anywhere in the oral cavity. Although the exact agent initiating LP is unknown, current research points to a number of complex immunologic events and cells that are responsible for the inflammatory destruction and chronicity of these lesions. Currently, the mainstay of treatment remains topical corticosteroids, but newer therapies such a tacrolimus are available for recalcitrant lesions. In cases of lichenoid mucositis or reactions, treatment should always be directed toward identifying and removing the presumed causative agent. Given the apparent risk of squamous cell carcinoma in these patients, frequent follow-up and repeat biopsy when indicated are vital.",
author = "DeRossi, {Scott S.} and Ciarrocca, {Katharine N.}",
year = "2005",
month = "1",
day = "1",
doi = "10.1016/j.cden.2004.08.004",
language = "English (US)",
volume = "49",
pages = "77--89",
journal = "Dental Clinics of North America",
issn = "0011-8532",
publisher = "W.B. Saunders Ltd",
number = "1 SPEC.ISS.",

}

TY - JOUR

T1 - Lichen planus, lichenoid drug reactions, and lichenoid mucositis

AU - DeRossi, Scott S.

AU - Ciarrocca, Katharine N.

PY - 2005/1/1

Y1 - 2005/1/1

N2 - OLP and lichenoid reaction are a relatively common oral mucosal disease process encountered in clinical practice. This mucocutaneous disease can manifest as desquamative gingivitis, asymptomatic Wickham's striae or plaques, or severe, painful erosions or ulcerations anywhere in the oral cavity. Although the exact agent initiating LP is unknown, current research points to a number of complex immunologic events and cells that are responsible for the inflammatory destruction and chronicity of these lesions. Currently, the mainstay of treatment remains topical corticosteroids, but newer therapies such a tacrolimus are available for recalcitrant lesions. In cases of lichenoid mucositis or reactions, treatment should always be directed toward identifying and removing the presumed causative agent. Given the apparent risk of squamous cell carcinoma in these patients, frequent follow-up and repeat biopsy when indicated are vital.

AB - OLP and lichenoid reaction are a relatively common oral mucosal disease process encountered in clinical practice. This mucocutaneous disease can manifest as desquamative gingivitis, asymptomatic Wickham's striae or plaques, or severe, painful erosions or ulcerations anywhere in the oral cavity. Although the exact agent initiating LP is unknown, current research points to a number of complex immunologic events and cells that are responsible for the inflammatory destruction and chronicity of these lesions. Currently, the mainstay of treatment remains topical corticosteroids, but newer therapies such a tacrolimus are available for recalcitrant lesions. In cases of lichenoid mucositis or reactions, treatment should always be directed toward identifying and removing the presumed causative agent. Given the apparent risk of squamous cell carcinoma in these patients, frequent follow-up and repeat biopsy when indicated are vital.

UR - http://www.scopus.com/inward/record.url?scp=9444222474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9444222474&partnerID=8YFLogxK

U2 - 10.1016/j.cden.2004.08.004

DO - 10.1016/j.cden.2004.08.004

M3 - Review article

C2 - 15567362

AN - SCOPUS:9444222474

VL - 49

SP - 77

EP - 89

JO - Dental Clinics of North America

JF - Dental Clinics of North America

SN - 0011-8532

IS - 1 SPEC.ISS.

ER -